NASDAQ:WGS • US81663L2007
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GENEDX HOLDINGS CORP (WGS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-24 | BTIG | Maintains | Buy -> Buy |
| 2026-02-24 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-09 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-12-22 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-15 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-12 | BTIG | Maintains | Buy -> Buy |
| 2025-11-04 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-29 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-29 | BTIG | Maintains | Buy -> Buy |
| 2025-10-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-22 | BTIG | Maintains | Buy -> Buy |
| 2025-10-20 | Canaccord Genuity | Initiate | Buy |
| 2025-09-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-04 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-30 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-09 | Piper Sandler | Initiate | Overweight |
| 2025-06-30 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-09 | Jefferies | Upgrade | Hold -> Buy |
| 2025-05-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-01 | TD Securities | Maintains | Buy -> Buy |
| 2025-02-19 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-01-07 | TD Cowen | Maintains | Buy -> Buy |
| 2024-10-30 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-30 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-10-30 | Craig-Hallum | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 202.566M -13.69% | 305.45M 50.79% | 427.539M 39.97% | 555.73M 29.98% | 693.84M 24.85% | 853.03M 22.94% | 1.055B 23.68% | 1.39B 31.75% | 1.259B -9.42% | |
| EBITDA YoY % growth | -136.46M 77.57% | -1.26M 99.08% | 12.147M 1,064.05% | 29.063M 139.26% | 78.901M 171.48% | 120.8M 53.10% | N/A | N/A | N/A | |
| EBIT YoY % growth | -170.194M 74.51% | -23.213M 86.36% | -13.077M 43.67% | 30.721M 334.92% | 61.762M 101.04% | 90.067M 45.83% | 201.06M 123.23% | 343.7M 70.94% | 459.55M 33.71% | |
| Operating Margin | -84.02% | -7.60% | -3.06% | 5.53% | 8.90% | 10.56% | 19.06% | 24.73% | 36.50% | |
| EPS YoY % growth | -5.59 83.23% | 0.23 104.11% | 1.40 508.70% | 0.70 -49.86% | 2.13 202.78% | 3.29 54.92% | 5.32 61.45% | 8.85 66.44% | 13.41 51.60% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.00 -98.40% | 0.13 -74.61% | 0.19 -60.25% | 0.30 117.46% | 0.14 3,163.40% | 0.45 257.97% | 0.62 216.29% | 0.56 84.12% | 0.20 42.86% | 0.57 24.44% | 0.65 4.92% |
| Revenue Q2Q % growth | 114.19M 33.15% | 132M 28.54% | 140.03M 19.95% | 146.47M 21.06% | 136.07M 19.16% | 152.49M 15.52% | 167.45M 19.58% | 175.82M 20.04% | 161.7M 18.84% | 180.79M 18.56% | 198.97M 18.82% |
| EBITDA Q2Q % growth | 1.515M 34.43% | 6.43M -69.13% | 11.534M -23.58% | 18.564M 68.93% | 16.817M 1,010.03% | 23.432M 264.42% | 29.543M 156.14% | 33.684M 81.45% | N/A | N/A | N/A |
| EBIT Q2Q % growth | 622.837K 113.69% | 8.601M -4.01% | 9.05M 378.38% | 11.373M 179.89% | 6.969M 1,018.91% | 16.968M 97.28% | 18.382M 103.12% | 10.302M -9.42% | N/A | N/A | N/A |
All data in USD
13 analysts have analysed WGS and the average price target is 170 USD. This implies a price increase of 114.97% is expected in the next year compared to the current price of 79.08.
GENEDX HOLDINGS CORP (WGS) will report earnings on 2026-04-28.
The consensus EPS estimate for the next earnings of GENEDX HOLDINGS CORP (WGS) is 0 USD and the consensus revenue estimate is 114.19M USD.
The consensus rating for GENEDX HOLDINGS CORP (WGS) is 84.6154 / 100 . This indicates that analysts generally have a positive outlook on the stock.